ArticleBMC cancer2026
Integrated and clinical validation of helicase-like transcription factor as a biomarker for hepatocellular carcinoma.
Zhiyu Ni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it